Product Advisory Board

Concert Pharmaceuticals benefits from frequent, in-depth interactions with its knowledgeable and experienced advisor team. The Product Advisory Board was established at Concert’s inception as a source of deep industry expertise to evaluate and contribute to development and commercialization strategies for the Company’s product pipeline.

Lee Brettman, M.D.
Chief Medical Officer, Alnara Pharmaceuticals; Former CEO, Dynogen Pharmaceuticals

Chuck Finn
CEO of RRD International; Former Senior Vice President, Quintiles

Dennis Giesing, Ph.D.
Head of Research, Cortria Corporation; Former executive, Aventis Pharmaceuticals

Eric Gordon
Partner Skyline Ventures; Former executive, Bristol-Myers Squibb

Dan Grau
Chief Executive Officer and Vice Chair, Cortria Corporation; Former Chief Operating Officer, CombinatoRx

Peter Barton Hutt
Senior Counsel, Covington & Burling; Former Chief Counsel, FDA

Jim O'Shea
Former President and Chief Operating Officer, Sepracor

Wendell Wierenga
Executive Vice President Research and Development Ambit; Former Senior Vice President, WW Head of R&D, Parke-Davis 

[ back to top ]